Neuroinflammation and Blood-Brain Barrier Changes in Capillary Amyloid Angiopathy

Inflammation and Alzheimer’s disease

Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514

The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders

Zlokovic, B. V. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.003 · Cited by 3,280

An Assessment of Oxidative Damage to Proteins, Lipids, and DNA in Brain from Patients with Alzheimer's Disease

Lyras, L., Cairns, N. J., Jenner, A., Jenner, P., & Halliwell, B. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68052061.x · Cited by 531

Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer's disease

Wang, J., Xiong, S., Xie, C., Markesbery, W. R., & Lovell, M. A. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03053.x · Cited by 452

Reactive oxygen species alter brain endothelial tight junction dynamics via RhoA, PI3 kinase and PKB signaling

Schreibelt, G., Kooij, G., Reijerkerk, A., van Doorn, R., Gringhuis, S. I., van der Pol, S., Weksler, B. B., Romero, I. A., Couraud, P., Piontek, J., et al. (2007) · The FASEB Journal · doi:10.1096/fj.07-8329com · Cited by 347

RAGE‐dependent signaling in microglia contributes to neuroinflammation, Aβ accumulation, and impaired learning/memory in a mouse model of Alzheimer's disease

Fang, F., Lue, L.-F., Yan, S., Xu, H., Luddy, J. S., Chen, D., Walker, D. G., Stern, D. M., Yan, S., Schmidt, A. M., et al. (2010) · The FASEB Journal · doi:10.1096/fj.09-139634 · Cited by 335

Amyloid Beta induces oxidative stress-mediated blood-brain barrier changes in capillary amyloid angiopathy

Carrano, A., Hoozemans, J. J. M., van der Vies, S. M., Rozemuller, A. J. M., van Horssen, J., & de Vries, H. E. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.3895 · Cited by 293

Reactive oxygen species mediate Rac-induced loss of cell-cell adhesion in primary human endothelial cells

van Wetering, S., van Buul, J. D., Quik, S., Mul, E. P. J., Anthony, E. C., ten Klooster, J. P., Collard, J. G., & Hordijk, P. L. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.9.1837 · Cited by 278

Neuroinflammation in Alzheimer's Disease: Mechanisms, Pathologic Consequences, and Potential for Therapeutic Manipulation

Hensley, K. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1414 · Cited by 258

Amyloid β-peptide1–42 alters tight junction protein distribution and expression in brain microvessel endothelial cells

Marco, S., & Skaper, S. D. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.03.047 · Cited by 176

T cell-mediated skin-brain axis: Bridging the gap between psoriasis and psychiatric comorbidities

Yang, J., Zhang, S., Wu, Q., Chen, P., Dai, Y., Long, J., Wu, Y., & Lin, Y. (2024) · Journal of Autoimmunity · doi:10.1016/j.jaut.2024.103176 · Cited by 25

The development of cerebral amyloid angiopathy in cerebral vessels. A review with illustrations based upon own investigated post mortem cases

Mendel, T. A., Wierzba‐Bobrowicz, T., Lewandowska, E., Stępień, T., & Szpak, G. M. (2013) · Polish Journal of Pathology · doi:10.5114/pjp.2013.39334 · Cited by 27

ICAM-1null C57BL/6 Mice Are Not Protected from Experimental Ischemic Stroke

Enzmann, G. U., Pavlidou, S., Vaas, M., Klohs, J., & Engelhardt, B. (2018) · Translational Stroke Research · doi:10.1007/s12975-018-0612-4 · Cited by 28

Inflammation, Nitro-Oxidative Stress, Impaired Autophagy, and Insulin Resistance as a Mechanistic Convergence Between Arterial Stiffness and Alzheimer’s Disease

Hendrickx, J. O., Martinet, W., Dam, D. V., & Meyer, G. R. Y. D. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.651215 · Cited by 28

Therapeutic nanotechnologies for Alzheimer’s disease: A critical analysis of recent trends and findings

Delbreil, P., Rabanel, J., Banquy, X., & Brambilla, D. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114397 · Cited by 25

Current non-invasive strategies for brain drug delivery: overcoming blood–brain barrier transport

Zheng, X., Yang, J., Hou, Y., Fang, Y., Wu, K., Song, Y., Liu, K., & Zhu, J. (2023) · Molecular Biology Reports · doi:10.1007/s11033-023-08968-3 · Cited by 27

Overlapping Protein Accumulation Profiles of CADASIL and CAA

Young, K. Z., Xu, G., Keep, S. G., Borjigin, J., & Wang, M. M. (2020) · American Journal Of Pathology · doi:10.1016/j.ajpath.2020.11.015 · Cited by 24

Diffuse white matter loss in a transgenic rat model of cerebral amyloid angiopathy

Lee, H., Xu, F., Liu, X., Koundal, S., Zhu, X. A., Davis, J., Yanez, D., Schrader, J. M., Stanisavljevic, A., Rothman, D. L., et al. (2020) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x20944226 · Cited by 22

Functional and Molecular Characterization of the Effect of Amyloid-β 42 on an in vitro Epithelial Barrier Model

Gheorghiu, M., Enciu, A., Popescu, B. O., & Gheorghiu, E. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-122374 · Cited by 22

Willin/FRMD6: A Multi-Functional Neuronal Protein Associated with Alzheimer’s Disease

Chen, D., Yu, W., Aitken, L., & Gunn‐Moore, F. J. (2021) · Cells · doi:10.3390/cells10113024 · Cited by 21

Alzheimer’s disease is an inherent, natural part of human brain aging: an integrated perspective

Ferrer, I. (2022) · Free Neuropathology · doi:10.17879/freeneuropathology-2022-3806 · Cited by 25

Caveolae-Mediated Transcytosis and Its Role in Neurological Disorders

Yang, K., Li, Q., Ruan, Y., Xia, Y., & Fang, Z. H. (2025) · Biomolecules · doi:10.3390/biom15040456 · Cited by 20

Harnessing the immune system for the treatment of Parkinson’s disease

Vedam‐Mai, V. (2021) · Brain Research · doi:10.1016/j.brainres.2021.147308 · Cited by 20

Integrating neuroinflammation biomarkers into the ATN(X) framework: Advances in Alzheimer's pathogenesis, diagnosis, and insights from non‐human primate models

Jin, Z., Lu, Y., Tang, H., & Cui, H. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70472 · Cited by 24

Accelerated amyloid angiopathy and related vascular alterations in a mixed murine model of Alzheimer´s disease and type two diabetes

Vargas-Soria, M., Ramos‐Rodríguez, J. J., del Marco, À., Hierro‐Bujalance, C., Carranza-Naval, M. J., Calvo-Rodríguez, M., van Veluw, S. J., Stitt, A. W., Simó, R., Bacskai, B. J., et al. (2022) · Fluids and Barriers of the CNS · doi:10.1186/s12987-022-00380-6 · Cited by 20

Elevated Cerebrospinal Fluid and Plasma N-Cadherin in Alzheimer Disease

Choi, J., Cho, S.-J., Park, J., Yun, S., Jo, C., Kim, E., Huh, G. Y., Park, M. H., Han, C., & Koh, Y. H. (2020) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlaa019 · Cited by 18

Key brain cell interactions and contributions to the pathogenesis of Alzheimer’s disease

Saavedra, J., Nascimento, M., Liz, M. A., & Cardoso, I. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1036123 · Cited by 16

Daucosterol confers protection against T-2 toxin induced blood-brain barrier toxicity through the PGC-1α-mediated defensive response in vitro and in vivo

Guo, P., Lu, Q., Hu, S., Yang, Y., Wang, X., Wang, X., & Wang, X. (2023) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2023.132262 · Cited by 15

Cerebrovascular and mitochondrial abnormalities in Alzheimer’s disease: a brief overview

Carvalho, C., Correia, S. C., Perry, G. L., Castellani, R. J., & Moreira, P. I. (2015) · Journal of Neural Transmission · doi:10.1007/s00702-015-1367-7 · Cited by 14

I2-Imidazoline Ligand CR4056 Improves Memory, Increases ApoE Expression and Reduces BBB Leakage in 5xFAD Mice

Mota, B. C., Ashburner, N., Abelleira, L. E., Liu, L., Aleksynas, R., Rovati, L. C., Caselli, G., & Sastre, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137320 · Cited by 15

Complement Activation in the Central Nervous System: A Biophysical Model for Immune Dysregulation in the Disease State

Peoples, N., & Strang, C. J. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.620090 · Cited by 14

Impact of Aβ40 and Aβ42 Fibrils on the Transcriptome of Primary Astrocytes and Microglia

Zhu, X. A., Schrader, J. M., Irizarry, B. A., Smith, S. O., & Nostrand, W. E. V. (2022) · Biomedicines · doi:10.3390/biomedicines10112982 · Cited by 14

Mild traumatic brain injury-induced persistent blood–brain barrier disruption is prevented by cyclosporine A treatment in hypertension

Lendvai-Emmert, D., Magyar-Sümegi, Z. D., Hegedus, E., Szarka, N., Fazekas, B., Amrein, K., Czeiter, E., Büki, A., Ungvari, Z. I., & Tóth, P. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1252796 · Cited by 13

Rebuilding insight into the pathophysiology of Alzheimer's disease through new blood-brain barrier models

Matsuo, K., & Nishihara, H. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.390978 · Cited by 14

The Role of Aging in Intracerebral Hemorrhage

Huang, B., Chen, A., Sun, Y., & He, Q. (2024) · Brain Sciences · doi:10.3390/brainsci14060613 · Cited by 15

Plasma S100β is a predictor for pathology and cognitive decline in Alzheimer’s disease

Nehra, G., Maloney, B. J., Smith, R. R., Chumboatong, W., Abner, E. L., Nelson, P. T., Bauer, B., & Hartz, A. M. S. (2025) · Fluids and Barriers of the CNS · doi:10.1186/s12987-024-00615-8 · Cited by 13

Cerebrovascular inflammation is associated with tau pathology in Guam parkinsonism dementia

Majerová, P., Garruto, R. M., & Kováč, A. (2018) · Journal of Neural Transmission · doi:10.1007/s00702-018-1883-3 · Cited by 13

CAR-T Cell Therapy-Related Neurotoxicity in Pediatric Acute Lymphoblastic Leukemia: Spectrum of Imaging Findings

Tan, A. P. (2020) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2020.06.014 · Cited by 13

Moyamoya disease: A human model for chronic hypoperfusion and intervention in Alzheimer's disease

Zou, X., Yuan, Y., Liao, Y., Jiang, C., Zhao, F., Ding, D., Gu, Y., Chen, L., Chu, Y., Hsu, Y., et al. (2022) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12285 · Cited by 13

Patient-Derived Blood-Brain Barrier Model for Screening Copper Bis(thiosemicarbazone) Complexes as Potential Therapeutics in Alzheimer’s Disease

Wasielewska, J. M., Szostak, K., McInnes, L. E., Quek, H., Chaves, J. C. S., Liddell, J. R., Koıstınaho, J., Oikari, L. E., Donnelly, P. S., & White, A. R. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00743 · Cited by 11

Genetic factors related to the immune system in subjects at risk of developing Alzheimer's disease

Prendecki, M., Kowalska, M., Łagan-Jędrzejczyk, U., Piekut, T., Krokos, A., Kozubski, W. P., & Dorszewska, J. (2020) · Journal of Integrative Neuroscience · doi:10.31083/j.jin.2020.02.110 · Cited by 11

Local perfusion of capillaries reveals disrupted beta-amyloid homeostasis at the blood-brain barrier in Tg2576 murine Alzheimer’s model

Hanafy, A. S., Lamprecht, A., & Dietrich, D. (2023) · Fluids and Barriers of the CNS · doi:10.1186/s12987-023-00492-7 · Cited by 11

Potential roles of brain barrier dysfunctions in the early stage of Alzheimer’s disease

Jian, W., Zhang, Z., Chu, S., Peng, Y., & Chen, N. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.08.012 · Cited by 12

Impact of Donepezil Supplementation on Alzheimer’s Disease-like Pathology and Gut Microbiome in APP/PS1 Mice

Li, Y., Wu, M., Kong, M., Sui, S., Wang, Q., He, Y., & Gu, J. (2023) · Microorganisms · doi:10.3390/microorganisms11092306 · Cited by 12

Ginsenoside Rb1 alleviates blood-brain barrier damage and demyelination in experimental autoimmune encephalomyelitis mice by regulating JNK/ ERK/NF-κB signaling pathway

Song, Y., Zhang, X., Han, X., Wang, G., Wang, M., Wu, H. M., & Wu, X. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.119448 · Cited by 10

Progressive human-like tauopathy with downstream neurodegeneration and neurovascular compromise in a transgenic rat model

Emmerson, J. T., Carmo, S. D., Liu, Y., Shalhoub, A., Ai, L., Bonomo, Q., Malcolm, J. C., Breuillaud, L., & Cuello, A. C. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106227 · Cited by 11

Liver X receptor alpha ensures blood-brain barrier function by suppressing SNAI2

Vacondio, D., Pinto, H. N., Coenen, L., Mulder, I. A., Fontijn, R. D., Hof, B. V. H., Fung, W. K., Jongejan, A., Kooij, G., Zelcer, N., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06316-8 · Cited by 12

Tissue blood volumes and weights in adult beagle dogs.

Cuddihy, R. G., Hall, R. P., HOBBS, C. H., Boecker, B. B., & Muggenburg, B. A. (1972) · OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) · Cited by 10

Large-scale cerebrospinal fluid proteomic analysis in Alzheimer’s disease patients reveals five molecular subtypes with distinct genetic risk profiles

Tijms, B. M., Vromen, E. M., Mjaavatten, O., Holstege, H., Reus, L. M., van der Lee, S., Wesenhagen, K. E., Lorenzini, L., Vermunt, L., Venkatraghavan, V., et al. (2023) · doi:10.1101/2023.05.10.23289793 · Cited by 10

Arbovirus infection increases the risk for the development of neurodegenerative disease pathology in the murine model

Fongsaran, C., Jirakanwisal, K., Peng, B.-H., Fracassi, A., Taglialatela, G., Dineley, K. T., Paessler, S., & Cisneros, I. E. (2024) · Brain, Behavior, & Immunity - Health · doi:10.1016/j.bbih.2024.100780 · Cited by 9

Decreased microvascular claudin‐5 levels in cerebral amyloid angiopathy associated with intracerebral haemorrhage

Jäkel, L., Claassen, K. K. W. J., de Kort, A. M., Jolink, W. M. T., Vermeiren, Y., Schreuder, F. H. B. M., Küsters, B., Klijn, C. J. M., Kuiperij, H. B., & Verbeek, M. M. (2024) · Brain Pathology · doi:10.1111/bpa.13270 · Cited by 8

The M1-like microglia-A1-like astrocyte Axis: A central hub linking BDNF dysregulation in chronic stress to anxiety disorders

Li, H., Zhu, Y., Liu, P., Song, S., Zhang, X., Liu, C., Hu, M., Zhang, Y., Wang, C., & Hu, Y. (2026) · Neurobiology of Disease · doi:10.1016/j.nbd.2026.107278 · Cited by 11

Sex Modifies the Associations of APOE ɛ4 with Neuropsychiatric Symptom Burden in Both At-Risk and Clinical Cohorts of Alzheimer’s Disease

Dissanayake, A. S., for the PACt-MD Study Group, Tan, Y. B., Bowie, C. R., Butters, M. A., Flint, A. J., Gallagher, D., Golas, A., Herrmann, N., Ismail, Z., et al. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220586 · Cited by 8

Anti‐inflammatory Agents from Medicinal Plants

Tùng, B. T., Linh, T. V., Thao, T. P., & Thuan, N. D. (2023) · Wiley eBooks · doi:10.1002/9781119794127.ch9 · Cited by 8

N-Acetylcysteine Attenuates Aβ-Mediated Oxidative Stress, Blood–Brain Barrier Leakage, and Renal Dysfunction in 5xFAD Mice

Ontawong, A., Nehra, G., Maloney, B. J., Vaddhanaphuti, C. S., Bauer, B., & Hartz, A. M. S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26094352 · Cited by 7

Dissecting the immune response of CD4+ T cells in Alzheimer’s disease

Kostić, M. S., Živković, N., Cvetanović, A., Bašić, J., & Stojanović, I. R. (2024) · Reviews in the Neurosciences · doi:10.1515/revneuro-2024-0090 · Cited by 8

The intersection of circadian rhythms and the blood-brain barrier with drug efficacy and delivery in neurological disorders

Schindler, K. A., Torices, S., Schurhoff, N. A., Gallo, D. I., & Toborek, M. J. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115645 · Cited by 8

Potential Intersections between lncRNA, Vascular Cognitive Impairment, and Immunization Strategies: Insights and Future Directions

Fan, Y., Xiao, B., & Zhang, M. (2024) · Vaccines · doi:10.3390/vaccines12030251 · Cited by 6

Endothelial-to-mesenchymal transition in the central nervous system: A potential therapeutic target to combat age-related vascular fragility

Vance, M. L., Nagy, D., Brunner, E., Morkotinis, V., Black, J. L., Refai, L. H., Csiszár, A., & Conley, S. M. (2025) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/j.jpet.2025.103747 · Cited by 6

Interactions between Cytokines and the Pathogenesis of Prion Diseases: Insights and Implications

Lemos, G. G. M., Moura-do-Nascimento, R., Amaral-do-Nascimento, M., Miceli, A. C., & Vieira, T. C. R. G. (2024) · Brain Sciences · doi:10.3390/brainsci14050413 · Cited by 6

ZO-1 Serum Levels as a Potential Biomarker for Psychotic Disorder

Avşar, P. A., & Akkuş, M. (2024) · Clinical Neuropharmacology · doi:10.1097/wnf.0000000000000590 · Cited by 5

Lychee seed polyphenol protects blood–retinal barrier by increasing tight joint proteins and inhibiting the activation of TLR4/MYD88/NF-κB-mediated NLRP3 inflammasome

Wei, J., Xiang, X.-H., Tang, Y., Qin, D., Wu, J., Yu, C., Qiu, W., Wu, A., & Lv, H. (2021) · Food and Agricultural Immunology · doi:10.1080/09540105.2021.1968352 · Cited by 5

Differential effects of Huang-Lian-Jie-Du Decoction on Alzheimer’s disease and normal rats

Xu, M., Zhu, Y., Chen, J., Zhong, F., Wang, R., Li, J., Qiao, M., Fan, Y., Ren, P., Chen, M., et al. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1710919 · Cited by 4

Perivascular spaces visible on magnetic resonance imaging predict subsequent delirium in older patients

Song, Q., Zhao, Y., Lin, T., & Yue, J. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.897802 · Cited by 4

Inhibition of NOX2 contributes to the therapeutic effect of aloin on traumatic brain injury

Dong, H., Wang, H., & Zhang, X. (2020) · Folia Neuropathologica · doi:10.5114/fn.2020.100069 · Cited by 4

Contrasting patterns of leptomeningeal and parenchymal gadolinium extravasation in cerebral amyloid angiopathy: An MRI-based evaluation

Voigt, S., de Jong, J., Voorter, P., Koemans, E. A., Schipper, M. R., van der Plas, M. C., Kaushik, K., van der Zwet, R. G. J., van Dort, R., van den Brink, H., et al. (2026) · International Journal of Stroke · doi:10.1177/17474930261424089 · Cited by 3

Adeno-associated Virus-Mediated Gene Delivery Across the Blood-Brain Barrier

Yao, Y., & Bei, F. (2024) · Advances in neurobiology · doi:10.1007/978-3-031-69188-1_4 · Cited by 3

Decoding Blood-Brain Barrier Dysfunction in Alzheimer's Disease: Innovations and Challenges in Multimodal MRI and PET Imaging Biomarkers.

Yin, H., Lu, Z., Deng, Y., Tian, X., & Gong, Q. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102952 · Cited by 6

Mesenchymal Stem Cell Therapy Modulates Peripheral–Central Immune Interactions and Attenuates Neuroinflammation-Driven Cognitive Dysfunction

Ayyubova, G., Huseynova, S. E., Mustafayeva, N., Yildirim, L., Ismayilova, S. H., Gasimova, T., & Aliyeva, S. A. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27031182 · Cited by 2

Recapitulating Alzheimer’s disease pathophysiology with a microfluidic neurospheroid-grafted endothelial barrier model

Uzoechi, S. C., Johnson-Campbell, C., Badeaux, C. J., Kwak, S. S., Kim, D. Y., & Yun, Y. (2026) · Molecular Brain · doi:10.1186/s13041-026-01285-3 · Cited by 2

The Role of Sphingosine-1-Phosphate Signaling in Cerebral Ischemia/Reperfusion Injury and Alzheimer’s Disease Pathology

Czubowicz, K., Motyl, J. A., Wencel, A., & Strosznajder, R. P. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27125200 · Cited by 2

Protective effect of scallop-derived plasmalogen against vascular dysfunction, via the pSTAT3/PIM1/NFATc1 axis, in a novel mouse model of Alzheimer’s disease with cerebral hypoperfusion

Zhai, Y., Morihara, R., Feng, T., Hu, X., Fukui, Y., Bian, Z., Bian, Y., Yu, H., Sun, H., Takemoto, M., et al. (2024) · Brain Research · doi:10.1016/j.brainres.2024.148790 · Cited by 2

ALZHEIMER HASTALIĞI, RİSK FAKTÖRLERİ VE TEDAVİ

Yıldırım, N., & Eke, B. C. (2024) · Ankara Universitesi Eczacilik Fakultesi Dergisi · doi:10.33483/jfpau.1441827 · Cited by 4

Comparative Analysis of Neurogenesis and Cerebral Angiogenesis in the Hippocampal Neurogenic Niche in Animals with Two Experimental Models of Alzheimer’s Disease

Сергеевич, А. А., Kukla, M. V., Rozanova, N. A., Stavrovskaya, A. V., & Salmina, A. B. (2025) · Annals of Clinical and Experimental Neurology · doi:10.17816/acen.1227 · Cited by 2

Transcriptional and post-transcriptional responses to amyloid- β in cerebral amyloid angiopathy

Florijn, B. W., Verwey, N. A., van Etten, E. S., de Vries, H. E., & Wermer, M. J. H. (2025) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x251366082 · Cited by 1

The role of blood-brain barrier disruption in spontaneous intracerebral haemorrhage and small vessel disease

Freeze, W. M. (2014) · Utrecht University Repository (Utrecht University)

[Rivoflavin fluorescence angiography (author's transl)].

Shimotori, M., & Aoki, S. (1975) · PubMed

Pathophysiology of the Blood–Brain Barrier in Neuroinflammatory Diseases

Majerová, P., & Kováč, A. (2017) · Springer eBooks · doi:10.1007/978-3-319-45514-3_4

Neuronal NOX4 knockdown alleviates pathological tau-related alterations in a humanized mouse model of tauopathyPreprint

Luengo, E., Trigo-Alonso, P., Fernández‐Mendívil, C., Núñez, Á., del Campo, M., Porrero, C., García‐Magro, N., Negredo, P., Sánchez‐Ramos, C., Bernal, J. A., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.10.14.338954

Cerebrovascular Dysfunction and Degeneration in Alzheimer’s Disease Pathophysiology

Quintana, D. D. (2020) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.7941

Taking Advantages of Blood–Brain Barrier to Optimize Delivery of Drugs in Central Neurological ConditionsPreprint

Hou, Y., Fang, Y., Wu, K., Song, Y., Liu, K., Zhu, J., & Zheng, X. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4661733

Unraveling Alzheimer's disease heterogeneity:

Vromen, E. M. (2024) · doi:10.5463/thesis.937

Differential Effects of Huang-Lian-Jie-Du Decoction on Alzheimer's and Normal RatsPreprint

Xu, M., Zhu, Y., Chen, J., Zhong, F., Wang, R., Li, J., Qiao, M., Fan, Y., Ren, P., Chen, M., et al. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5260839

Prediction of postoperative delirium in the elderly using imaging markers of cerebral small vessel disease

Zhang, Z., Chen, Y., Jiao, H., Zhang, T., Meng, D., Mo, N., Wang, X., Hong, J., Mu, D.-L., Li, Z., et al. (2026) · BMC Anesthesiology · doi:10.1186/s12871-026-03859-z

Additional file 1 of Local perfusion of capillaries reveals disrupted beta-amyloid homeostasis at the blood-brain barrier in Tg2576 murine Alzheimer’s model

Hanafy, A. S., Lamprecht, A., & Dietrich, D. (2023) · Figshare · doi:10.6084/m9.figshare.24628136

Additional file 1 of Effects of acute and chronic oxidative stress on the blood–brain barrier in 2D and 3D in vitro models

Chung, T. D., Linville, R. M., Guo, Z., Ye, R., Jha, R., Grifno, G. N., & Searson, P. C. (2022) · Figshare · doi:10.6084/m9.figshare.19759518

Additional file 3 of Retinal capillary degeneration and blood-retinal barrier disruption in murine models of Alzheimer’s disease

Shi, H., Koronyo, Y., Fuchs, D.-T., Sheyn, J., Wawrowsky, K., Lahiri, S., Black, K. L., & Koronyo‐Hamaoui, M. (2020) · Figshare · doi:10.6084/m9.figshare.13279800

Additional file 1 of Deep learning assisted quantitative assessment of histopathological markers of Alzheimer’s disease and cerebral amyloid angiopathy

Perosa, V., Scherlek, A. A., Kozberg, M. G., Smith, L., Westerling-Bui, T., Auger, C. A., Vasylechko, S., Greenberg, S. M., & van Veluw, S. J. (2021) · Figshare · doi:10.6084/m9.figshare.16305697

Mesenchymal Stromal Cell Therapeutic Potential to Restore Neurovascular Integrity in Machado-Joseph DiseasePreprint

Barros, I., Gonzaga, D., Lobo, D., Lopes, S., Martins, I. M., Silva, A., Silva, C. H., Gomes, C. M. F., Nobre, R. J., de Almeida, L. P., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.31.703043

Impact de l’infection à Helicobacter pylori sur la maladie d’Alzheimer

Baudron, C. R. (2014) · theses.fr (ABES) · doi:10.70675/201f68e4z646cz4e66z80e2zd8a4b726fbe7

Implication du récepteur sérotoninergique 5-HT4 dans la modulation de la perméabilité de la barrière hémato-encéphalique

Becker, G. (2021) · theses.fr (ABES) · doi:10.70675/4e9b29c7z0775z47f0zb6f3z07cef62d92ef

A blood-brain barrier model based on flexible tubes to tailor the biophysical and chemical environment for drug delivery testing

Alexaki, M., Marino, A., Lefevre, M. C., Canale, C., Odino, D., Mano, J. F., Oliveira, M., & Ciofani, G. (2026) · Materials Today Bio · doi:10.1016/j.mtbio.2026.103307

Theranostic Innovative Strategies for Brain Diseases: New Insights on Neurovascular Unit-Associated Pathological Changes in Neurodegenerative Disorders and Aging

Terribile, G., Pedrinazzi, M., Frigerio, I., Sancini, G., & Combi, R. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27167165

Gut–Brain–Skin Axis: From Mechanistic Insights to Translational Applications in Neurocosmetics

Zhao, R., Xu, H., Zhu, Y., Chang, H., Liu, B., & Liu, Z. (2026) · Dermatology and Therapy · doi:10.1007/s13555-026-01892-x

Proteomics Reveals Blood−Brain Barrier Membrane Protein Remodeling in Amyloid-β Pathology

Hyvärinen, J., Todorovska, R., Palacios, M. D. P., Gynther, M., Afonin, A., Lehtonen, M., Auriola, S., Saveleva, L., Kanninen, K. M., Fricker, G., et al. (2026) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6c00935

Molecular Pathogenesis of Cerebral Amyloid Angiopathy in Alzheimer’s Disease: The Role of the Central Fibrinolytic Cascade at the Neurovascular Unit

Kumar, S., Paswan, S. K., Verma, P., Chaturvedi, S., Vishwakarma, V. K., & Yadav, H. N. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-06263-3

Amyloid Beta induces oxidative stress-mediated blood-brain barrier changes in capillary amyloid angiopathy

Carrano, A., Hoozemans, J. J. M., van der Vies, S. M., Rozemuller, A. J. M., van Horssen, J., & de Vries, H. E. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.3895 · Cited by 293

P2‐263: Oxidative stress and tight junctions alterations in capillary cerebral amyloid angiopathy

Carrano, A., van Horssen, J., de Vries, H. E., & Rozemüller, A. J. M. (2010) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.05.1313

The effects of cerebral amyloid angiopathy on integrity of the blood-brain barrier

Magaki, S., Tang, Z., Tung, S., Williams, C. K., Lo, D., Yong, W. H., Khanlou, N., & Vinters, H. V. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.06.004 · Cited by 93

Amyloid-β Contributes to Blood–Brain Barrier Leakage in Transgenic Human Amyloid Precursor Protein Mice and in Humans With Cerebral Amyloid Angiopathy

Hartz, A. M. S., Bauer, B., Soldner, E. L. B., Wolf, A., Boy, S., Backhaus, R., Mihaljevic, I., Bogdahn, U., Klünemann, H. H., Schuierer, G., et al. (2012) · Stroke · doi:10.1161/strokeaha.111.627562 · Cited by 248

Brain endothelial dysfunction in AD

de Vries, H. E. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.059640 · Cited by 1